. 32-year-old male with multifocal renal carcinoid and thyroid metastases. Contrast-enhanced coronal reformatted CT shows horseshoe kidney with enhancing nodules within the isthmus (arrow) and a large enhancing lesion within right moiety with an area of necrosis (*); additional lesions are present.
A CT guided fine needle aspiration (FNA) of the right kidney mass showed numerous single cells and small tissue fragments composed of a monotonous population of cells with oval to round nuclei, fine chromatin and a moderate amount of granular eosinophilic cytoplasm (Fig 1D) . Areas of necrosis were also seen. Virtually all cells were strongly positive by immunohistochemistry for synaptophysin ( Fig  1E) , a neuroendocrine marker, and pancytokeratin (AE1,3), but negative for renal cell carcinoma (RCC) antigen and thyroid transcription factor (TTF-1). An immunostain for calcitonin was negative and serum calcitonin was also negative, thus excluding metastatic medullary carcinoma of the thyroid. An FNA of the thyroid lesion showed identical morphological and immunohistochemical findings (Fig 1F) . These findings were interpreted as renal carcinoid with metastasis to the thyroid.
After the diagnosis of renal carcinoid was made, the patient underwent a somatostatin receptor scintigraphy (OctreoScan) to look for additional tumor foci. Octreotide, a somatostatin analogue, binds to somatostatin receptors which are expressed in more than 80% of carcinoid tumors and whose sensitivity for detecting carcinoid tumors is greater than 85% [3, 4] . There was increased activity in both kidneys and the thyroid gland; however the specificity of these findings was limited because octreotide is renally excreted and may have normal activity within the thyroid gland. More importantly, there was increased activity within the pleural based lesion and within the left adrenal lesion consistent with octreotide avid metastatic foci. There was no abnormal activity within the liver.
Therapeutic planning was complicated and involved a multidisciplinary team. This gentleman was healthy and a
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total nephrectomy would place him on dialysis. Moreover, any surgical intervention would be very difficult because of the size, location, and the nature of the blood supply to horseshoe kidneys. Renal function at the time of diagnosis was only mildly decreased with a creatinine of 1.6. He is being empirically treated with Sandostatin on a monthly basis, despite the lack of any carcinoid symptoms and will be rescanned for response.
Discussion
Carcinoid tumor cells arise from enterochromaffin or amine precursor uptake and decarboxylation cells. Carcinoid tumors can arise anywhere in the body but most frequently develop in the gastrointestinal tract and bronchial system of the lungs [5] . Enterochromaffin cells are not found in normal renal parenchyma making renal carcinoids extremely rare with less than forty cases in the English literature. Both primary and metastatic renal carcinoids have been reported. Even though some carcinoid tumors show a gender predilection, renal carcinoid tumors occur without any gender predominance [6] .
Several groups have noted an association between primary renal carcinoid tumors and horseshoe kidneys with a relative risk ranging from 62 to 82 compared with normal kidneys [1, 2] . The pathogenesis of renal carcinoid tumor is subject to debate and may be different for horseshoe and non-horseshoe variants. Any hypothesis must account for the fact that neuroendocirine cells have not been identified in the normal kidney. Krishnan et al. have postulated that primary renal carcinoid tumors may be more frequently encountered in horseshoe kidneys because of the increased incidence of aberrant epithelium or teratomatous elements within these kidneys [1] .
Renal carcinoids are often detected incidentally or because of abdominal pain or hematuria. However, they are usually very large at detection with an average size of 10.5 cm (range 1.2 to 30 cm). This is much larger than the typical non renal carcinoid tumors of which almost fifty percent measure less than 1 cm [6] . Unfortunately, imaging characteristics for renal carcinoids are nonspecific and overlap with those of renal cell carcinomas-that of a cystic and or solid enhancing mass. They have been noted to contain areas of necrosis, hemorrhage and calcification; however, there are no specific imaging findings on CT or MRI. Renal carcinoid is a histopathological diagnosis which employs immunohistochemical stains to confirm the neuroendocrine nature of the tumor [7] .
Predicting the clinical course and prognosis of renal carcinoid tumor is difficult because of the paucity of cases. Carcinoid syndrome is rarely associated with renal carcinoids even in instances of metastases to liver [2] . The majority of cases is unifocal and is amenable to resection even in the presence of distant metastases. A recent review by Kawajiri et al. reported a 25.7% incidence of metastases with renal carcinoid. The most frequent sites of metastases were to lymph nodes, liver, and bones which reflects the pattern of spread from carcinoid tumor arising in other organs [6] . The review by Krishnan et al. of 32 cases of renal carcinoid suggested a more benign course for patients with the horseshoe subtype. In fact, a more recent review of the literature reveals only two cases of metastases related to a horseshoe kidney, and the authors at the time of publication suggested an optimistic outlook [2, 8] .
Our case is unique because of its multifocal, bilateral involvement with over twenty foci identified, pathologically proven metastases to the thyroid, and presumed metastases to the pleura and left adrenal gland.
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